Vaccitech plc
VACC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $128 | $127 | $127 | $124 |
| - Cash | $74 | $86 | $99 | $111 |
| + Debt | $12 | $12 | $12 | $12 |
| Enterprise Value | $65 | $53 | $40 | $25 |
| Revenue | $0 | $0 | $0 | $14 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $23 |
| % Margin | – | – | – | 159.2% |
| EBITDA | -$14 | $0 | $0 | -$8 |
| % Margin | – | – | – | -59.8% |
| Net Income | -$15 | -$21 | -$20 | -$5 |
| % Margin | – | – | – | -35.1% |
| EPS Diluted | -0.36 | -0.52 | -0.49 | -0.08 |
| % Growth | 30.8% | -6.1% | -512.5% | – |
| Operating Cash Flow | -$11 | -$18 | -$15 | $2 |
| Capital Expenditures | $0 | -$0 | -$0 | $5 |
| Free Cash Flow | -$11 | -$18 | -$15 | $7 |